LETYBO Trademark

Trademark Overview


On Thursday, June 13, 2019, a trademark application was filed for LETYBO with the United States Patent and Trademark Office. The USPTO has given the LETYBO trademark a serial number of 79266012. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by HUGEL INC.. The LETYBO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical products for skin care for animals; pharmaceutical preparations used in cosmetic surgery; pharmaceutical preparations containing botulinum toxin; botulinum toxin for medical use for use in the treatment of neuropathy pain; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; pharmaceutical preparations for use in treating urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; bacterial toxins, namely, bacterial poisons; pharmaceutical preparations for digestive system; pharmacological preparations for skin care; pharmaceutical preparations for treating peripheral neurological diseases and disorders; pharmaceutical preparations for treating central neurological diseases and disorder...
letybo

General Information


Serial Number79266012
Word MarkLETYBO
Filing DateThursday, June 13, 2019
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6181983
Registration DateTuesday, October 27, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Certificate of Correction for RegistrationIn statement Class 5, has been corrected per the F-note dated 4/11/2024.
Goods and ServicesPharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical products for skin care for animals; pharmaceutical preparations used in cosmetic surgery; pharmaceutical preparations containing botulinum toxin; botulinum toxin for medical use for use in the treatment of neuropathy pain; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; pharmaceutical preparations for use in treating urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; bacterial toxins, namely, bacterial poisons; pharmaceutical preparations for digestive system; pharmacological preparations for skin care; pharmaceutical preparations for treating peripheral neurological diseases and disorders; pharmaceutical preparations for treating central neurological diseases and disorders; ophthalmic preparations for use in the treatment of blepharospasm and strabismus; medicated ointments for treating dermatological conditions; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical agents for epidermis; drugs for medical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; biological preparations for medical or veterinary purposes for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; cultures of microorganisms for medical or veterinary use; chemical reagents for medical or veterinary purposes; bacteriological preparations for medical and veterinary use; adjuvants for medical purposes; hyaluronic acid preparations for medical purposes; medicines for human purpose, namely, medicines for skin care; pharmaceutical preparations for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of orthopaedic disorders, namely, hip dislocation, spinal column deformation, curvature of the spine, namely, scoliosis, lordosis, cyphosis; pharmaceutical preparations for smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, tremors and pain; pharmaceutical preparations for the treatment of wrinkles; injectable dermal filler; medicines for dental purposes; preparation for the relief of pain; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations mainly based on hyaluronic acid for treatments, namely, injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; therapeutic drugs and agents for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHUGEL INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameHUGEL INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameHUGEL INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Wednesday, September 4, 2019ASSIGNED TO EXAMINER
Thursday, August 22, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, August 26, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, September 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 5, 2019NON-FINAL ACTION WRITTEN
Friday, September 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 10, 2019APPLICATION FILING RECEIPT MAILED
Monday, September 16, 2019REFUSAL PROCESSED BY MPU
Monday, September 16, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 5, 2019REFUSAL PROCESSED BY IB
Thursday, March 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2020PUBLISHED FOR OPPOSITION
Tuesday, May 12, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 6, 2020WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 22, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, August 7, 2020NOTIFICATION PROCESSED BY IB
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, February 6, 2021FINAL DISPOSITION PROCESSED
Wednesday, January 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, March 17, 2024CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, April 11, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Friday, April 12, 2024CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, May 21, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Saturday, February 6, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 27, 2021NEW REPRESENTATIVE AT IB RECEIVED
Sunday, March 7, 2021FINAL DECISION TRANSACTION PROCESSED BY IB